Triantafyllos Chavakis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Triantafyllos Chavakis has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Valeria Viktorovna Orlova
Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, The Netherlands
8 shared publications Matina Economopoulou
Experimental Immunology Branch, National Cancer Institute, Bethesda, USA
6 shared publicationsKlaus T. Preissner
Institute of Biochemistry, Justus-Liebig-University Giessen, D-35392 Giessen, Germany
5 shared publicationsDarius Schneider
‡ Department of Internal Medicine I, University Heidelberg, D-69120 Heidelberg
4 shared publications- Eun Young Choi
Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul 05505, Korea
4 shared publications Mathias Herrmann
Institute of Medical Microbiology and Hygiene, University of Saarland Hospital, D-66421 Homburg/Saar, Germany
4 shared publications
Latest Publications
- 15 January 2011
- Published by The Company of Biologists in Development
- Vol. 138 (2) , e0208
Targeted JAM-C deletion in germ cells by Spo11-controlled Cre recombinase
- 15 January 2011
- Published by The Company of Biologists in Development
- Vol. 138 (2) , e0208
Targeted JAM-C deletion in germ cells by Spo11-controlled Cre recombinase
- 1 February 2010
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 42 (2) , 193-197
Crosstalk between the DNA damage response, histone modifications and neovascularisation
- 1 February 2010
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 42 (2) , 193-197
Crosstalk between the DNA damage response, histone modifications and neovascularisation
- Open Access
- 1 November 2009
- Published by Taylor & Francis in Cell Cycle
- Vol. 8 (21) , 3438-3439
A possible crosstalk between DNA repair pathways and angiogenesis
Postnatal neovascularization is triggered by tissue hypoxia and the hypoxia-inducible transcription factor dependent upregulation of vascular growth factors. At the same time hypoxia is associated with replication stress and can induce a cellular DNA repair response including the phosphorylation of histone H2AX. Recent findings point to a role of H2AX in endothelial cell proliferation under hypoxia and thereby in hypoxia-driven neovascularization.
- 1 November 2009
- Published by Taylor & Francis in Cell Cycle
- Vol. 8 (21) , 3438-3439
Open AccessA possible crosstalk between DNA repair pathways and angiogenesis
Postnatal neovascularization is triggered by tissue hypoxia and the hypoxia-inducible transcription factor dependent upregulation of vascular growth factors. At the same time hypoxia is associated with replication stress and can induce a cellular DNA repair response including the phosphorylation of histone H2AX. Recent findings point to a role of H2AX in endothelial cell proliferation under hypoxia and thereby in hypoxia-driven neovascularization.
- Open Access
- 30 July 2009
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 13 (7) , 1211-1220
Leukocyte – endothelial interactions in inflammation
Introduction Adhesion molecules Leukocyte margination, capture and cell rolling Activation and adhesion of leukocytes Transmigration Endogenous inhibitors of leukocyte adhesion Platelet–leukocyte crosstalk Conclusions At sites of inflammation, infection or vascular injury local proinflammatory or pathogen‐derived stimuli render the luminal vascular endothelial surface attractive for leukocytes. This innate immunity response consists of a well‐defined and regulated multi‐step cascade involving consecutive steps of adhesive interactions between the leukocytes and the endothelium. During the initial contact with the activated endothelium leukocytes roll along the endothelium via a loose bond which is mediated by selectins. Subsequently, leukocytes are activated by chemokines presented on the luminal endothelial surface, which results in the activation of leukocyte integrins and the firm leukocyte arrest on the endothelium. After their firm adhesion, leukocytes make use of two transmigration processes to pass the endothelial barrier, the transcellular route through the endothelial cell body or the paracellular route through the endothelial junctions. In addition, further circulating cells, such as platelets arrive early at sites of inflammation contributing to both coagulation and to the immune response in parts by facilitating leukocyte–endothelial interactions. Platelets have thereby been implicated in several inflammatory pathologies. This review summarizes the major mechanisms and molecules involved in leukocyte–endothelial and leukocyte‐platelet interactions in inflammation.
- 30 July 2009
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 13 (7) , 1211-1220
Open AccessLeukocyte – endothelial interactions in inflammation
Introduction Adhesion molecules Leukocyte margination, capture and cell rolling Activation and adhesion of leukocytes Transmigration Endogenous inhibitors of leukocyte adhesion Platelet–leukocyte crosstalk Conclusions At sites of inflammation, infection or vascular injury local proinflammatory or pathogen‐derived stimuli render the luminal vascular endothelial surface attractive for leukocytes. This innate immunity response consists of a well‐defined and regulated multi‐step cascade involving consecutive steps of adhesive interactions between the leukocytes and the endothelium. During the initial contact with the activated endothelium leukocytes roll along the endothelium via a loose bond which is mediated by selectins. Subsequently, leukocytes are activated by chemokines presented on the luminal endothelial surface, which results in the activation of leukocyte integrins and the firm leukocyte arrest on the endothelium. After their firm adhesion, leukocytes make use of two transmigration processes to pass the endothelial barrier, the transcellular route through the endothelial cell body or the paracellular route through the endothelial junctions. In addition, further circulating cells, such as platelets arrive early at sites of inflammation contributing to both coagulation and to the immune response in parts by facilitating leukocyte–endothelial interactions. Platelets have thereby been implicated in several inflammatory pathologies. This review summarizes the major mechanisms and molecules involved in leukocyte–endothelial and leukocyte‐platelet interactions in inflammation.
- 19 April 2009
- Published by Springer Nature in Nature Medicine
- Vol. 15 (5) , 553-558
Histone H2AX is integral to hypoxia-driven neovascularization
Hypoxia-triggered neovascularization occurs in many types of disease. Endothelial cells must be able to cope with hypoxic stress, which in other cell types can induce a DNA repair response and inhibit replication. Matina Economopoulou et al. now show that hypoxia induces the generation of a hallmark of the DNA repair response, phosphorylated histone H2AX, in proliferating endothelial cells and that H2AX function is required for neovascularization under hypoxic or ischemic conditions in vivo pages 491–493 .. H2A histone family member X (H2AX, encoded by H2AFX) and its C-terminal phosphorylation (γ-H2AX) participates in the DNA damage response and mediates DNA repair1,2,3,4,5,6. Hypoxia is a physiological stress that induces a replication-associated DNA damage response7. Moreover, hypoxia is the major driving force for neovascularization8, as the hypoxia-mediated induction of vascular growth factors triggers endothelial cell proliferation8. Here we studied the role of the hypoxia-induced DNA damage response in endothelial cell function and in hypoxia-driven neovascularization in vivo. Hypoxia induced replication-associated generation of γ-H2AX in endothelial cells in vitro and in mice. Both in cultured cells and in mice, endothelial cell proliferation under hypoxic conditions was reduced by H2AX deficiency. Whereas developmental angiogenesis was not affected in H2afx−/− mice, hypoxia-induced neovascularization during pathologic proliferative retinopathy, in response to hind limb ischemia or during tumor angiogenesis was substantially lower in H2afx−/− mice. Moreover, endothelial-specific H2afx deletion resulted in reduced hypoxia-driven retina neovascularization and tumor neovascularization. Our findings establish that H2AX, and hence activation of the DNA repair response, is needed for endothelial cells to maintain their proliferation under hypoxic conditions and is crucial for hypoxia-driven neovascularization.
- 19 April 2009
- Published by Springer Nature in Nature Medicine
- Vol. 15 (5) , 553-558
Histone H2AX is integral to hypoxia-driven neovascularization
Hypoxia-triggered neovascularization occurs in many types of disease. Endothelial cells must be able to cope with hypoxic stress, which in other cell types can induce a DNA repair response and inhibit replication. Matina Economopoulou et al. now show that hypoxia induces the generation of a hallmark of the DNA repair response, phosphorylated histone H2AX, in proliferating endothelial cells and that H2AX function is required for neovascularization under hypoxic or ischemic conditions in vivo pages 491–493 .. H2A histone family member X (H2AX, encoded by H2AFX) and its C-terminal phosphorylation (γ-H2AX) participates in the DNA damage response and mediates DNA repair1,2,3,4,5,6. Hypoxia is a physiological stress that induces a replication-associated DNA damage response7. Moreover, hypoxia is the major driving force for neovascularization8, as the hypoxia-mediated induction of vascular growth factors triggers endothelial cell proliferation8. Here we studied the role of the hypoxia-induced DNA damage response in endothelial cell function and in hypoxia-driven neovascularization in vivo. Hypoxia induced replication-associated generation of γ-H2AX in endothelial cells in vitro and in mice. Both in cultured cells and in mice, endothelial cell proliferation under hypoxic conditions was reduced by H2AX deficiency. Whereas developmental angiogenesis was not affected in H2afx−/− mice, hypoxia-induced neovascularization during pathologic proliferative retinopathy, in response to hind limb ischemia or during tumor angiogenesis was substantially lower in H2afx−/− mice. Moreover, endothelial-specific H2afx deletion resulted in reduced hypoxia-driven retina neovascularization and tumor neovascularization. Our findings establish that H2AX, and hence activation of the DNA repair response, is needed for endothelial cells to maintain their proliferation under hypoxic conditions and is crucial for hypoxia-driven neovascularization.
- 1 January 2009
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 102 (08) , 191-197
Novel aspects in the regulation of the leukocyte adhesion cascade
Summary: Leukocyte recruitment plays a major role in the immune response to infectious pathogens and during inflammatory and autoimmune disorders. The process of leukocyte extravasation from the blood into the inflamed tissue requires a complex cascade of adhesive events between the leukocytes and the endothelium including leukocyte rolling, adhesion and transendothelial migration. Leukocyte-endothelial interactions are mediated by tightly regulated binding interactions between adhesion receptors on both cells. In this regard, leukocyte adhesion onto the endothelium is governed by leukocyte integrins and their endothelial counter-receptors of the immunoglobulin superfamily. The present review will focus on novel aspects with respect to the modulation of the leukocyte adhesion cascade.
- 1 January 2009
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 102 (08) , 191-197
Novel aspects in the regulation of the leukocyte adhesion cascade
Summary: Leukocyte recruitment plays a major role in the immune response to infectious pathogens and during inflammatory and autoimmune disorders. The process of leukocyte extravasation from the blood into the inflamed tissue requires a complex cascade of adhesive events between the leukocytes and the endothelium including leukocyte rolling, adhesion and transendothelial migration. Leukocyte-endothelial interactions are mediated by tightly regulated binding interactions between adhesion receptors on both cells. In this regard, leukocyte adhesion onto the endothelium is governed by leukocyte integrins and their endothelial counter-receptors of the immunoglobulin superfamily. The present review will focus on novel aspects with respect to the modulation of the leukocyte adhesion cascade.
- 14 November 2008
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 322 (5904) , 1101-1104
Del-1, an Endogenous Leukocyte-Endothelial Adhesion Inhibitor, Limits Inflammatory Cell Recruitment
Leukocyte recruitment to sites of infection or inflammation requires multiple adhesive events. Although numerous players promoting leukocyte-endothelial interactions have been characterized, functionally important endogenous inhibitors of leukocyte adhesion have not been identified. Here we describe the endothelially derived secreted molecule Del-1 (developmental endothelial locus–1) as an anti-adhesive factor that interferes with the integrin LFA-1–dependent leukocyte-endothelial adhesion. Endothelial Del-1 deficiency increased LFA-1–dependent leukocyte adhesion in vitro and in vivo. Del-1 –/– mice displayed significantly higher neutrophil accumulation in lipopolysaccharide-induced lung inflammation in vivo, which was reversed in Del-1/LFA-1 double-deficient mice. Thus, Del-1 is an endogenous inhibitor of inflammatory cell recruitment and could provide a basis for targeting leukocyte-endothelial interactions in disease.
- 14 November 2008
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 322 (5904) , 1101-1104
Del-1, an Endogenous Leukocyte-Endothelial Adhesion Inhibitor, Limits Inflammatory Cell Recruitment
Leukocyte recruitment to sites of infection or inflammation requires multiple adhesive events. Although numerous players promoting leukocyte-endothelial interactions have been characterized, functionally important endogenous inhibitors of leukocyte adhesion have not been identified. Here we describe the endothelially derived secreted molecule Del-1 (developmental endothelial locus–1) as an anti-adhesive factor that interferes with the integrin LFA-1–dependent leukocyte-endothelial adhesion. Endothelial Del-1 deficiency increased LFA-1–dependent leukocyte adhesion in vitro and in vivo. Del-1 –/– mice displayed significantly higher neutrophil accumulation in lipopolysaccharide-induced lung inflammation in vivo, which was reversed in Del-1/LFA-1 double-deficient mice. Thus, Del-1 is an endogenous inhibitor of inflammatory cell recruitment and could provide a basis for targeting leukocyte-endothelial interactions in disease.
- Open Access
- 1 September 2007
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 282 (37) , 26746-26753
Vascular Endothelial Growth Factor (VEGF)-induced Up-regulation of CCN1 in Osteoblasts Mediates Proangiogenic Activities in Endothelial Cells and Promotes Fracture Healing
- 1 September 2007
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 282 (37) , 26746-26753
Open AccessVascular Endothelial Growth Factor (VEGF)-induced Up-regulation of CCN1 in Osteoblasts Mediates Proangiogenic Activities in Endothelial Cells and Promotes Fracture Healing
- 1 September 2007
- Published by Elsevier in Trends in Immunology
- Vol. 28 (9) , 408-418
The anti-inflammatory activities of Staphylococcus aureus
- 1 September 2007
- Published by Elsevier in Trends in Immunology
- Vol. 28 (9) , 408-418
The anti-inflammatory activities of Staphylococcus aureus
- 1 August 2007
- Vol. 98 (2) , 327-32
Regulation of vascular endothelial permeability by junctional adhesion molecules (JAM).
The vascular endothelium forms a barrier between the circulation and the interstitium, and changes in vascular permeability are very important during vascular repair and inflammatory conditions. The regulation of the endothelial barrier depends on actomyosin-related cell contractility as well as the integrity of cell-cell junctions, such as tight and adherens junctions. The present review will introduce the basic pathways involved in the regulation of the endothelial barrier as well as important participating signaling players, such as the small GTPases RhoA, Rac and Rap1. In this context, we will attempt to analyze and interpret the recent evidence pointing to the role of the family of junctional adhesion molecules (JAMs) in modulating the pathways involved in the regulation of the endothelial barrier.
- 1 August 2007
- Vol. 98 (2) , 327-32
Regulation of vascular endothelial permeability by junctional adhesion molecules (JAM).
The vascular endothelium forms a barrier between the circulation and the interstitium, and changes in vascular permeability are very important during vascular repair and inflammatory conditions. The regulation of the endothelial barrier depends on actomyosin-related cell contractility as well as the integrity of cell-cell junctions, such as tight and adherens junctions. The present review will introduce the basic pathways involved in the regulation of the endothelial barrier as well as important participating signaling players, such as the small GTPases RhoA, Rac and Rap1. In this context, we will attempt to analyze and interpret the recent evidence pointing to the role of the family of junctional adhesion molecules (JAMs) in modulating the pathways involved in the regulation of the endothelial barrier.